Avantax Advisory Services, Inc. Genmab A/S Transaction History
Avantax Advisory Services, Inc.
- $17.6 Billion
- Q2 2025
A detailed history of Avantax Advisory Services, Inc. transactions in Genmab A/S stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 71,635 shares of GMAB stock, worth $2.28 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
71,635
Previous 72,394
1.05%
Holding current value
$2.28 Million
Previous $1.42 Million
4.38%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding GMAB
# of Institutions
242Shares Held
65.1MCall Options Held
32.5KPut Options Held
55K-
Alliancebernstein L.P. New York, NY10.7MShares$339 Million0.08% of portfolio
-
Orbis Allan Gray LTD Hamilton, D07.92MShares$252 Million1.07% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$162 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.57MShares$114 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA3.45MShares$110 Million0.05% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $20.9B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...